Understanding U-100 insulin syringes and units in research
What U-100 insulin syringes measure, how to read units as volume, and why they suit small-volume peptide research.
Researchers working with reconstituted peptide solutions often reach for U-100 insulin syringes, because they measure very small volumes with fine precision. Understanding what the markings mean is mainly a matter of reading a volume scale correctly.
What "U-100" means
U-100 describes a graduation standard, not a substance. It means the barrel is calibrated so that 100 units correspond to exactly one millilitre of liquid. The number refers only to how the syringe is marked; the device itself holds nothing until it is filled in the laboratory.
Reading units as volume
On a U-100 scale, one unit equals one-hundredth of a millilitre — ten microlitres. This makes the unit a convenient shorthand for small volumes: 50 units is 0.5 mL and 20 units is 0.2 mL. Treating units purely as a measure of volume avoids confusion at the bench.
Why they suit small-volume work
Reconstituted peptide solutions are frequently handled in fractions of a millilitre. The closely spaced graduations of a U-100 barrel let researchers read these quantities more precisely than a larger syringe would allow, which is why they appear so often in benchtop measurement.
Relating concentration to units
Because a unit is only a volume, the amount of peptide contained in a given number of units depends entirely on the concentration of the reconstituted solution. A more concentrated preparation holds more material per unit. Our reconstitution guide and the on-site reconstitution simulator both help visualise how concentration and volume relate.
Consistency and record-keeping
Whatever device is used, consistency is what makes measurements comparable. Recording concentration in defined terms and reading the same graduation the same way each time is what keeps laboratory measurements reproducible.
Keep reading
More from the
research bench.
Retatrutide: the triple agonist explained
One molecule, three receptor pathways. Why retatrutide is one of the most closely watched compounds in modern metabolic research.
Tirzepatide: the dual GIP/GLP-1 agonist
How engaging two incretin pathways at once set tirzepatide apart, and what researchers study it for.
Why modified peptides last longer: half-life and modifications
How amino-acid substitutions, fatty-acid chains and added size extend a peptide's half-life, and why it matters in research.
